List Drug Candidate

BioNeex Interviews

BioNeex Interviews are part of the BioNeex vision. They provide a social media exposure to early stage biotech companies and their R&D pipelines in order to attract the right licensing and co-development partners. During the interview the interviewee, typically a biotech CEO, addresses the company’s message to potential partners, investors and other external stakeholders.
BioNeex Interview with Director Chief Scientific Officer of Moexa Pharmaceuticals, Dr. Stephen Porter

Interview with Director & Chief Scientific Officer of Moexa Pharmaceuticals, Dr. Stephen Porter

Jan 12, 2022

Cancer Therapies
CEO of Moexa Pharmaceuticals Anthony Desir

Interview with the CEO of Moexa Pharmaceuticals, Anthony Desir

Nov 29, 2022

Immuno-Oncology
BioNeex Interview with the Co-Founder CEO of Oncolyze, Dr Steven Evans

Interview with the Co-Founder & CEO of Oncolyze, Dr. Steven Evans

Oct 17, 2022

Cancer Therapies
BioNeex Interview with CEO of PepVax - Mahesh Narayanan

Interview with President & CEO of PepVax, Mahesh Narayanan

Jul 5, 2022

Immunotherapies
Bioneex-Angel Garcia Martin

Interview with Co-Founder & CEO of Odylia Therapeutics, Scott Dorfman

Mar 30, 2022

Gene Therapy
BioNeex Interview with President and Director of BioCorRx, Brady Granier

Interview with President and Director of BioCorRx, Brady Granier

Feb 10, 2022

Neurology
Bioneex Interview with the Founder and President of AptamiR Therapeutics, Dr. Marc Thibonnier

Interview with the Founder and President of AptamiR Therapeutics, Dr. Marc Thibonnier

Feb 17, 2023

Cancer Therapies
Interview with the CSO of Bright Minds Biosciences Dr Jan Torleif Pedersen

Interview with the CSO of Bright Minds Biosciences, Dr. Jan Torleif Pedersen

May 31, 2023

Clinical Stage
BioNeex Interview with CEO and Co-Founder of Repair Biotechnologies Reason

Interview with CEO and Co-Founder of Repair Biotechnologies, Reason

Nov 2, 2021

Cardiovascular Therapies